FUTURE-HF: Novel IVC sensor may help control volume and improve function outcomes

A new implantable inferior vena cava (IVC) sensor appeared safe, accurate, and helpful in controlling volume in patients with heart failure (HF). Using the device was also associated with improvements in functional outcomes. “The ‘goldilocks zone’ of IVC-based HF management lies between a pressure of 10–25 mmHg,” according to Dr Kevin Damman (University Medical Center Groningen, the Netherlands) [1]. “And if we wait for pressure to rise, it is often already too late to avoid decompensation.” The novel IVC sensor, FIRE1, aims to measure IVC area and collapsibility, which could help manage patients with HF and keep them in the ‘goldilocks zone’. Dr Damman discussed the outcomes of the FUTURE-HF portfolio, including 50 patients with HF from the non-randomised first-in-human clinical investigation, open-label FUTURE-HF study (NCT04203576) and 15 patients with HF from the non-randomised, open-label, sin...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 17 July 202521 July 2025